Quick Summary:
In the progressive and ever-dynamic Pharmaceutical industry, staying well-informed on recent advances and trends is crucial. As such, acquiring our comprehensive market research report on the Global Thin Film Drug Manufacturing Market can serve as a powerful tool in navigating this market, projected to reach a value of US$21.3 Billion by 2030. With robust growth expected in this sector, strategic decision-making based on up-to-the-minute data, analyzed and balanced, can provide a valuable competitive edge.
Our report offers an insightful and thorough analysis of the market, focusing on important segments such as Oral Thin Film and Transdermal Thin Film. With the U.S. Market estimated at $3.6 Billion, and China poised for significant growth, this report provides detailed profiles of key global regions. The research also includes an in-depth look at leading competitors within the industry, providing necessary comparisons to determine market positioning. All this relevant and comprehensive information is ideal to aid you in formulating effective growth strategies.
Global Thin Film Drug Manufacturing Market to Reach $21.3 Billion by 2030
The global market for Thin Film Drug Manufacturing estimated at US$11.9 Billion in the year 2022, is projected to reach a revised size of US$21.3 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Oral Thin Film, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Transdermal Thin Film segment is readjusted to a revised 8.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 7.2% CAGR
The Thin Film Drug Manufacturing market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.Select Competitors (Total 47 Featured) -
- Allergan plc
- Indivior plc
- IntelGenx Corp.
- MonoSol Rx
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- Wolters Kluwer
- ZIM Laboratories Limited
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Thin Film Drug Manufacturing?
What is the growth rate of the Global Market for Thin Film Drug Manufacturing?
What is the forecasted size of the Global Market for Thin Film Drug Manufacturing?
Who are the key companies in the Global Market for Thin Film Drug Manufacturing?
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 11.9 Billion |
| Forecasted Market Value ( USD | $ 21.3 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Allergan plc
- Indivior plc
- IntelGenx Corp.
- MonoSol Rx
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- Wolters Kluwer
- ZIM Laboratories Limited
